Prognostic Value of Excision Repair Cross-Complementing mRNA Expression in Gastric Cancer

Table 3

The prognostic value of the mRNA expression of ERCC in different treatment GC patients.

Genes	Treatment	cases	HR (95% CI)	P-value
ERCC1	surgery	174	1.29 (0.85–1.96)	0.22
	5-Fu	153	0.49 (0.33–0.72)	0.00023
ERCC2	surgery	174	0.84 (0.55–1.27)	0.4
	5-Fu	153	1.37 (0.95–1.99)	0.092
ERCC3	surgery	174	1.26 (0.82–1.92)	0.29
	5-Fu	153	2.2 (1.5–3.22)	0.00035
ERCC4	surgery	174	1.8 (1.19–2.74)	0.0049
	5-Fu	153	1.41 (0.99–1.99)	0.053
ERCC5	surgery	174	0.78 (0.5–1.21)	0.26
	5-Fu	153	1.28 (0.9–1.81)	0.16
ERCC6	surgery	174	1.7 (1.03–2.79)	0.035
	5-Fu	153	1.49 (1.04–2.12)	0.028
ERCC8	surgery	174	1.41 (0.92–2.14)	0.11
	5-Fu	34	2.25 (0.79–6.4)	0.12

Notes. ERCC, excision repair cross-complementing; GC, gastric cancer; HR, hazard ratio; CI, confidence interval.